Dravite Therapeutics, Inc. — Form D/A

Dravite Therapeutics, Inc. of SAN FRANCISCO, CA, a company, filed a Form D amendment with the SEC on 2026-07-28. The offering totals $15.0M, of which $15.0M was reported sold. Industry: Other.

Offering

• Filed: 2026-07-28
• Form: D/A
• Accession: 0001231919-26-000801
• Industry: Other
• Exemptions: 06b
• Total offering: $15.0M
• Amount sold: $15.0M
• Investors: 8
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-588496

Issuer

• Name: Dravite Therapeutics, Inc.
• CIK: 0002133272
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 401 CAMBRIDGE STREET 401 CAMBRIDGE ST, SAN FRANCISCO, CA, 94134
• Phone: 650-269-3210

Officers, directors & promoters (5)

Other filings by this issuer (1)

More

• CIK 2133272 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search